About: Saratoga Opthalmology

For patients with diabetic retinopathy, intravitreal anti-VEGF injections appear to have largely similar cardiovascular risks as steroid or laser treatments, but there is one caveat. Source: AAO

• Posted on: Jan 24 2023
• By: Saratoga Opthalmology
• Leave a reponse

Citing a multistate cluster of eye infections linked with EzriCare Artificial Tears, the CDC recommends clinicians and patients immediately stop use of the eye drop. Source: AAO

• Posted on: Jan 21 2023
• By: Saratoga Opthalmology
• Leave a reponse

A systematic literature review was conducted to examine the clinical use of apparent diffusion coefficient values as a diagnostic tool in differentiating benign from malignant orbital lesions. Source: AAO

• Posted on: Jan 20 2023
• By: Saratoga Opthalmology
• Leave a reponse

Racial and ethnic representation in studies of retinal vascular disease do not match distribution within the US population according to US Census data. Source: AAO

• Posted on: Jan 19 2023
• By: Saratoga Opthalmology
• Leave a reponse

The use of visors in National Football League games can help protect against ocular injury, but they are not always consistently used. Source: AAO

• Posted on: Jan 19 2023
• By: Saratoga Opthalmology
• Leave a reponse

Enhanced depth imaging OCT (EDI-OCT) appears to offer superior sensitivity, specificity, and accuracy in diagnosing optic disc drusen (ODD) compared to traditional imaging modalities. Source: AAO

• Posted on: Jan 18 2023
• By: Saratoga Opthalmology
• Leave a reponse

Mobile vision screening identifies vision correction needs in preschoolers, vision impairment is common in older adults, having AMD increases the risk of renal disease, and many recipient corneas are positive for the herpes simplex virus. Source: AAO

• Posted on: Jan 13 2023
• By: Saratoga Opthalmology
• Leave a reponse

Greater financial rewards associated with intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy over pars plana vitrectomy may lead to bias in choosing the most appropriate treatment. Source: AAO

• Posted on: Jan 12 2023
• By: Saratoga Opthalmology
• Leave a reponse

Alternative biologic therapy has been advanced as a treatment option for children with uveitis whose disease is unresponsive to both methotrexate and conventional tumor necrosis factor inhibitors. Source: AAO

• Posted on: Jan 11 2023
• By: Saratoga Opthalmology
• Leave a reponse

Nonvisual complications of orbital cellulitis may occur in the months following hospitalization, even when the cellulitis has resolved. Source: AAO

• Posted on: Jan 10 2023
• By: Saratoga Opthalmology
• Leave a reponse